161 related articles for article (PubMed ID: 19318567)
1. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.
Huang M; Itahana K; Zhang Y; Mitchell BS
Cancer Res; 2009 Apr; 69(7):3004-12. PubMed ID: 19318567
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
Lo D; Dai MS; Sun XX; Zeng SX; Lu H
J Biol Chem; 2012 Mar; 287(13):10013-10020. PubMed ID: 22318725
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption.
Huang M; Ji Y; Itahana K; Zhang Y; Mitchell B
Leuk Res; 2008 Jan; 32(1):131-41. PubMed ID: 17462731
[TBL] [Abstract][Full Text] [Related]
4. Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival.
Meng L; Lin T; Tsai RY
J Cell Sci; 2008 Dec; 121(Pt 24):4037-46. PubMed ID: 19033382
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.
Huang M; Whang P; Chodaparambil JV; Pollyea DA; Kusler B; Xu L; Felsher DW; Mitchell BS
J Biol Chem; 2011 Apr; 286(13):11035-46. PubMed ID: 21242306
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Dai MS; Sun XX; Lu H
Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
[TBL] [Abstract][Full Text] [Related]
7. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
Elife; 2014 Oct; 3():. PubMed ID: 25347121
[TBL] [Abstract][Full Text] [Related]
8. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT
Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179
[TBL] [Abstract][Full Text] [Related]
9. Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop.
Lo D; Lu H
Cell Cycle; 2010 Aug; 9(16):3227-32. PubMed ID: 20703089
[TBL] [Abstract][Full Text] [Related]
10. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.
Tin AS; Park AH; Sundar SN; Firestone GL
BMC Biol; 2014 Sep; 12():72. PubMed ID: 25209720
[TBL] [Abstract][Full Text] [Related]
11. MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity.
Saha MN; Jiang H; Jayakar J; Reece D; Branch DR; Chang H
Cancer Biol Ther; 2010 Jun; 9(11):936-44. PubMed ID: 20418664
[TBL] [Abstract][Full Text] [Related]
12. Nucleostemin: a multiplex regulator of cell-cycle progression.
Ma H; Pederson T
Trends Cell Biol; 2008 Dec; 18(12):575-9. PubMed ID: 18951797
[TBL] [Abstract][Full Text] [Related]
13. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
14. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
15. Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
Davis JR; Mossalam M; Lim CS
Mol Pharm; 2013 Apr; 10(4):1340-9. PubMed ID: 23398638
[TBL] [Abstract][Full Text] [Related]
16. A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin.
Tsai RY; McKay RD
J Cell Biol; 2005 Jan; 168(2):179-84. PubMed ID: 15657390
[TBL] [Abstract][Full Text] [Related]
17. MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.
Chen G; Huang H; Fröhlich O; Yang Y; Klein JD; Price SR; Sands JM
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1528-34. PubMed ID: 18784257
[TBL] [Abstract][Full Text] [Related]
18. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.
Jin Y; Zeng SX; Sun XX; Lee H; Blattner C; Xiao Z; Lu H
Mol Cell Biol; 2008 Feb; 28(4):1218-29. PubMed ID: 18086887
[TBL] [Abstract][Full Text] [Related]
19. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
20. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.
Meng L; Hsu JK; Tsai RY
Oncogene; 2011 Apr; 30(14):1716-26. PubMed ID: 21132010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
